Global and China Medical Grade Chitosan Market Insights, Forecast to 2027

Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.

Market Analysis and Insights: Global and China Medical Grade Chitosan Market
This report focuses on global and China Medical Grade Chitosan market.
In 2020, the global Medical Grade Chitosan market size was US$ 32 million and it is expected to reach US$ 53 million by the end of 2027, with a CAGR of 7.8% during 2021-2027. In China the Medical Grade Chitosan market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Medical Grade Chitosan Scope and Market Size
Medical Grade Chitosan market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Grade Chitosan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Medical Grade Chitosan market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Animal Origin Chitosan
Plant Based Chitosan

Segment by Application
Wound Care
Healthcare Products
Antibacterial Products
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry